BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 30400063)

  • 1. Soluble CD163 was linked to galectin-3, diabetic retinopathy and antidepressants in type 1 diabetes.
    Melin EO; Dereke J; Thunander M; Hillman M
    Endocr Connect; 2018 Dec; 7(12):1343-1353. PubMed ID: 30400063
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Female sex, high soluble CD163, and low HDL-cholesterol were associated with high galectin-3 binding protein in type 1 diabetes.
    Melin EO; Dereke J; Hillman M
    Biol Sex Differ; 2019 Nov; 10(1):51. PubMed ID: 31752995
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Depression in type 1 diabetes was associated with high levels of circulating galectin-3.
    Melin EO; Dereke J; Thunander M; Hillman M
    Endocr Connect; 2018 Jun; 7(6):819-828. PubMed ID: 29760188
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Galectin-3 Binding Protein, Depression, and Younger Age Were Independently Associated With Alexithymia in Adult Patients With Type 1 Diabetes.
    Melin EO; Svensson R; Dereke J; Hillman M
    Front Psychiatry; 2021; 12():672931. PubMed ID: 34045984
    [No Abstract]   [Full Text] [Related]  

  • 5. Low levels of soluble TWEAK, indicating on-going inflammation, were associated with depression in type 1 diabetes: a cross-sectional study.
    Melin EO; Dereke J; Hillman M
    BMC Psychiatry; 2020 Dec; 20(1):574. PubMed ID: 33261587
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Galectin-3, metalloproteinase-2 and cardiovascular disease were independently associated with metalloproteinase-14 in patients with type 1 diabetes: a cross sectional study.
    Melin EO; Dereke J; Hillman M
    Diabetol Metab Syndr; 2021 Oct; 13(1):118. PubMed ID: 34702365
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Soluble CD163 and glycated haemoglobin were independently associated with the progression of diabetic retinopathy in adult patients with type 1 diabetes.
    Hector S; Thulesius HO; Landin-Olsson M; Hillman M; Melin EO
    BMJ Open Ophthalmol; 2023 Jul; 8(1):. PubMed ID: 37493689
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lower HDL-cholesterol, a known marker of cardiovascular risk, was associated with depression in type 1 diabetes: a cross sectional study.
    Melin EO; Thulesius HO; Hillman M; Svensson R; Landin-Olsson M; Thunander M
    Lipids Health Dis; 2019 Mar; 18(1):65. PubMed ID: 30885233
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Abdominal obesity in type 1 diabetes associated with gender, cardiovascular risk factors and complications, and difficulties achieving treatment targets: a cross sectional study at a secondary care diabetes clinic.
    Melin EO; Thulesius HO; Hillman M; Landin-Olsson M; Thunander M
    BMC Obes; 2018; 5():15. PubMed ID: 29785272
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Midnight salivary cortisol secretion and the use of antidepressants were associated with abdominal obesity in women with type 1 diabetes: a cross sectional study.
    Melin EO; Hillman M; Thunander M; Landin-Olsson M
    Diabetol Metab Syndr; 2019; 11():88. PubMed ID: 31687046
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Monocyte CD163 is altered in association with diabetic complications: possible protective role.
    Min D; Brooks B; Wong J; Aamidor S; Seehoo R; Sutanto S; Harrisberg B; Yue DK; Twigg SM; McLennan SV
    J Leukoc Biol; 2016 Dec; 100(6):1375-1383. PubMed ID: 27354410
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Depression differed by midnight cortisol secretion, alexithymia and anxiety between diabetes types: a cross sectional comparison.
    Melin EO; Thunander M; Landin-Olsson M; Hillman M; Thulesius HO
    BMC Psychiatry; 2017 Sep; 17(1):335. PubMed ID: 28931368
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Soluble plasma proteins ST2 and CD163 as early biomarkers of nephropathy in Swedish patients with diabetes, 15-34 years of age: a prospective cohort study.
    Samuelsson M; Dereke J; Svensson MK; Landin-Olsson M; Hillman M;
    Diabetol Metab Syndr; 2017; 9():41. PubMed ID: 28559931
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Changes in fat mass correlate with changes in soluble sCD163, a marker of mature macrophages, in patients with CKD.
    Axelsson J; Møller HJ; Witasp A; Qureshi AR; Carrero JJ; Heimbürger O; Bárány P; Alvestrand A; Lindholm B; Moestrup SK; Stenvinkel P
    Am J Kidney Dis; 2006 Dec; 48(6):916-25. PubMed ID: 17162146
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Higher levels of the soluble receptor for advanced glycation end products and lower levels of the extracellular newly identified receptor for advanced glycation end products were associated with lipid-lowering drugs in patients with type 1 diabetes: a comparative cross-sectional study.
    Melin EO; Dereke J; Hillman M
    Lipids Health Dis; 2020 Oct; 19(1):223. PubMed ID: 33054750
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gender, alexithymia and physical inactivity associated with abdominal obesity in type 1 diabetes mellitus: a cross sectional study at a secondary care hospital diabetes clinic.
    Melin EO; Svensson R; Thunander M; Hillman M; Thulesius HO; Landin-Olsson M
    BMC Obes; 2017; 4():21. PubMed ID: 28588898
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Soluble CD163, a specific macrophage activation marker, is decreased by anti-TNF-α antibody treatment in active inflammatory bowel disease.
    Dige A; Støy S; Thomsen KL; Hvas CL; Agnholt J; Dahlerup JF; Møller HJ; Grønbaek H
    Scand J Immunol; 2014 Dec; 80(6):417-23. PubMed ID: 25346048
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adiponectin downregulates CD163 whose cellular and soluble forms are elevated in obesity.
    Sporrer D; Weber M; Wanninger J; Weigert J; Neumeier M; Stögbauer F; Lieberer E; Bala M; Kopp A; Schäffler A; Buechler C
    Eur J Clin Invest; 2009 Aug; 39(8):671-9. PubMed ID: 19490068
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Macrophage activity assessed by soluble CD163 in early rheumatoid arthritis: association with disease activity but different response patterns to synthetic and biologic DMARDs.
    Greisen SR; Møller HJ; Stengaard-Pedersen K; Hetland ML; Hørslev-Petersen K; Junker P; Østergaard M; Hvid M; Deleuran B
    Clin Exp Rheumatol; 2015; 33(4):498-502. PubMed ID: 25962601
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Overexpression of CD163 in vitreous and fibrovascular membranes of patients with proliferative diabetic retinopathy: possible involvement of periostin.
    Kobayashi Y; Yoshida S; Nakama T; Zhou Y; Ishikawa K; Arita R; Nakao S; Miyazaki M; Sassa Y; Oshima Y; Izuhara K; Kono T; Ishibashi T
    Br J Ophthalmol; 2015 Apr; 99(4):451-6. PubMed ID: 25281471
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.